While Eli Lilly and Company has warning labels about the most common side effects of their GIP/GLP-1 medications, the language on these labels may not have provided adequate warnings about serious GI health risks such as stomach paralysis, intestinal blockages, bowel obstruction, or frequent and excessive vomiting
Women with endometriosis may experience weight changes related to hormonal treatments or reduced physical activity due to pain
The researchers identified the mechanism: glycine activates the mTORC1 signaling pathway, the master switch for muscle protein synthesis
Tirzepatide may cause side effects such as nausea, vomiting, diarrhea, constipation, fatigue, decreased appetite, and stomach discomfort
monitor renal function if volume depletion suspected